Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Inventory Average (2019 - 2025)

Historic Inventory Average for Akebia Therapeutics (AKBA) over the last 7 years, with Q3 2025 value amounting to $17.7 million.

  • Akebia Therapeutics' Inventory Average fell 2031.78% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 2031.78%. This contributed to the annual value of $16.0 million for FY2024, which is 1429.18% down from last year.
  • Per Akebia Therapeutics' latest filing, its Inventory Average stood at $17.7 million for Q3 2025, which was down 2031.78% from $18.2 million recorded in Q2 2025.
  • Akebia Therapeutics' Inventory Average's 5-year high stood at $52.9 million during Q1 2021, with a 5-year trough of $17.1 million in Q4 2023.
  • For the 5-year period, Akebia Therapeutics' Inventory Average averaged around $28.4 million, with its median value being $22.2 million (2024).
  • Its Inventory Average has fluctuated over the past 5 years, first plummeted by 6287.9% in 2021, then soared by 1957.88% in 2024.
  • Quarter analysis of 5 years shows Akebia Therapeutics' Inventory Average stood at $35.2 million in 2021, then fell by 4.99% to $33.4 million in 2022, then plummeted by 48.91% to $17.1 million in 2023, then increased by 7.63% to $18.4 million in 2024, then decreased by 3.77% to $17.7 million in 2025.
  • Its Inventory Average was $17.7 million in Q3 2025, compared to $18.2 million in Q2 2025 and $18.0 million in Q1 2025.